References
- Chamberlain MC, Kormanik PA. AIDS-related central nervous system lymphomas. J Neurooncol 1999; 43(3)269–76
- Baumgartner JE, Rachlin JR, Beckstead JH, Meeker TC, Levy RM, Wara WM, et al. Primary central nervous system lymphomas: natural history and response to radiation therapy in 55 patients with acquired immunodeficiency syndrome. J Neurosurg 1990; 73(2)206–11
- Fine HA, Mayer RJ. Primary central nervous system lymphoma. Ann Intern Med 1993; 119(11)1093–104
- Henry JM, Heffner RR, Jr, Dillard SH, Earle KM, Davis RL. Primary malignant lymphomas of the central nervous system. Cancer 1974; 34(4)1293–302
- Pels H, Schmidt-Wolf IG, Glasmacher A, Schulz H, Engert A, Diehl V, et al. Primary central nervous system lymphoma: results of a pilot and phase II study of systemic and intraventricular chemotherapy with deferred radiotherapy. J Clin Oncol 2003; 21(24)4489–95
- Abrey LE, DeAngelis LM, Yahalom J. Long-term survival in primary CNS lymphoma. J Clin Oncol 1998; 16(3)859–63
- Shibamoto Y, Tsuchida E, Seki K, Oya N, Hasegawa M, Toda Y, et al. Primary central nervous system lymphoma in Japan 1995–1999: changes from the preceding 10 years. J Cancer Res Clin Oncol 2004; 130(6)351–6
- Salvesen Haldorsen I, Aarseth JH, Hollender A, Larsen JL, Espeland A, Mella O. Incidence, clinical features, treatment and outcome of primary central nervous system lymphoma in Norway. Acta Oncol 2004; 43(6)520–9
- Goldkuhl C, Ekman T, Wiklund T, Telhaug R. Age-adjusted chemotherapy for primary central-nervous system lymphoma–a pilot study. Acta Oncol 2002; 41(1)29–35
- Schlegel U, Schmidt-Wolf IG, Deckert M. Primary CNS lymphoma: clinical presentation, pathological classification, molecular pathogenesis and treatment. J Neurol Sci 2000; 181(1–2)1–12
- Bataille B, Delwail V, Menet E, Vandermarcq P, Ingrand P, Wager M, et al. Primary intracerebral malignant lymphoma: report of 248 cases. J Neurosurg 2000; 92(2)261–6
- Herrlinger U, Schabet M, Bitzer M, Petersen D, Krauseneck P. Primary central nervous system lymphoma: from clinical presentation to diagnosis. J Neurooncol 1999; 43(3)219–26
- Buhring U, Herrlinger U, Krings T, Thiex R, Weller M, Kuker W. MRI features of primary central nervous system lymphomas at presentation. Neurology 2001; 57(3)393–6
- Cartmill M, Allibone R, Bessell EM, Byrne PO. Primary cerebral non-Hodgkin's lymphoma: problems with diagnosis and development of a protocol for management. Br J Neurosurg 2000; 14(4)313–5
- Ferreri AJ, Blay JY, Reni M, Pasini F, Spina M, Ambrosetti A, et al. Prognostic scoring system for primary CNS lymphomas: the International Extranodal Lymphoma Study Group experience. J Clin Oncol 2003; 21(2)266–72
- Skiest DJ, Crosby C. Survival is prolonged by highly active antiretroviral therapy in AIDS patients with primary central nervous system lymphoma. AIDS 2003; 17(12)1787–93
- Newell ME, Hoy JF, Cooper SG, DeGraaff B, Grulich AE, Bryant M, et al. Human immunodeficiency virus-related primary central nervous system lymphoma: factors influencing survival in 111 patients. Cancer 2004; 100(12)2627–36
- Remick SC, Diamond C, Migliozzi JA, Solis O, Wagner H, Jr, Haase RF, et al. Primary central nervous system lymphoma in patients with and without the acquired immune deficiency syndrome. A retrospective analysis and review of the literature. Medicine (Baltimore) 1990; 69(6)345–60
- Krogh-Jensen M, D'Amore F, Jensen MK, Christensen BE, Thorling K, Pedersen M, et al. Clinicopathological features, survival and prognostic factors of primary central nervous system lymphomas: trends in incidence of primary central nervous system lymphomas and primary malignant brain tumors in a well-defined geographical area. Population-based data from the Danish Lymphoma Registry, LYFO, and the Danish Cancer Registry. Leuk Lymphoma 1995; 19(3–4)223–33
- Braus DF, Schwechheimer K, Muller-Hermelink HK, Schwarzkopf G, Volk B, Mundinger F. Primary cerebral malignant non-Hodgkin's lymphomas: a retrospective clinical study. J Neurol 1992; 239(3)117–24
- Herrlinger U, Schabet M, Clemens M, Kortmann RD, Petersen D, Will BE, et al. Clinical presentation and therapeutic outcome in 26 patients with primary CNS lymphoma. Acta Neurol Scand 1998; 97(4)257–64
- Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457–81
- Cox DR. Regression models and life tables. J Roy Statist Soc 1972; 34: 187–220
- Krogh-Jensen M, D'Amore F, Jensen MK, Christensen BE, Thorling K, Pedersen M, et al. Incidence, clinicopathological features and outcome of primary central nervous system lymphomas. Population-based data from a Danish lymphoma registry. Danish Lymphoma Study Group, LYFO. Ann Oncol 1994; 5(4)349–54
- Salander P, Bergenheim AT, Hamberg K, Henriksson R. Pathways from symptoms to medical care: a descriptive study of symptom development and obstacles to early diagnosis in brain tumour patients. Fam Pract 1999; 16(2)143–8
- Hochberg FH, Miller DC. Primary central nervous system lymphoma. J Neurosurg 1988; 68(6)835–53
- Goodson WH, III, Moore DH. Causes of physician delay in the diagnosis of breast cancer. Arch Intern Med 2002; 162(12)1343–8
- DeAngelis LM, Hormigo A. Treatment of primary central nervous system lymphoma. Semin Oncol 2004; 31(5)684–92
- Ammassari A, Scoppettuolo G, Murri R, Pezzotti P, Cingolani A, Del Borgo C, et al. Changing disease patterns in focal brain lesion-causing disorders in AIDS. J Acquir Immune Defic Syndr Hum Retrovirol 1998; 18(4)365–71